Skip to main content

Waiting on a Culture: Impact of pharmacist-led microresult follow-up post-discharge

Episode Notes

In this episode, Dr. April Dyer discusses a recent article in Antimicrobial Stewardship and Hospital Epidemiology on how pharmacists can help with post-hospital discharge micro result review. The article reviewed in today's episode can be found here: https://www.cambridge.org/core/journals/antimicrobial-stewardship-and-healthcare-epidemiology/article/impact-of-pharmacistled-microbiology-result-followup-postdischarge-for-patients-undergoing-inpatient-infectious-diseases-consultation/ED155B2C10D145480228E715ABCFB000

For more information about DASON, please visit: https://dason.medicine.duke.edu/

Ep.92 – Is One Better Than the Other? Analyzing surrogates for oral cephalosporin susceptibilities

Episode Notes

In this exciting episode, Dr. Jeannette Bouchard is joined by Drs. Katie Lambert and Catessa Howard to discuss their newly published brief report in OFID that helps shine a light on a common clinical issue, is cefazolin or ceftriaxone a better surrogate for third generation oral cephalosporins.

The article reviewed in this episode can be found here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11245689/

For more information about DASON, please visit: https://dason.medicine.duke.edu/

Ep.90 – It Goes On and On and On: Reviewing the new RCT for Continuous infusion vs. Intermittent infusion Beta-lactams

In this exciting episode, Drs. Libby Dodds Ashley and Jeannette Bouchard are joined by Dr. Jason Roberts to discuss his two newly published articles in JAMA that help to answer the question: is there a difference between continuous and intermittent infusions of beta-lactam antibiotics, especially in the critically ill populations?

The reviewed materials can be found here: https://dason.medicine.duke.edu/blog/it-goes-and-and-reviewing-new-rct-continuous-infusion-vs-intermittent-infusion-beta-lactams

For more information about DASON, please visit: https://dason.medicine.duke.edu/

Ep.88 – Is the debate back?: A retrospective study in patients with sepsis who received piperacillin-tazobactam vs. cefepime

Episode Notes

In this episode, Dr. Jeannette Bouchard discusses a newly published article in JAMA about the use of piperacillin-tazobactam and cefepime in sepsis. This episode also ties into a previous episode (#74) and we would recommend listening to both episodes!

The article reviewed in this episode can be found here: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2818278

For more information about DASON, please visit: https://dason.medicine.duke.edu/

Ep.87 – BCI(De-escalation): The Impact of Rapid Diagnostics and Stewardship Intervention on Treatment of Contaminated Blood Cultures

Episode Notes

In this episode, University of Kentucky Infectious Diseases Pharmacy Residents, Will Harris and Tyler Pitcock, review a recently published article evaluating the impact of the implementation of rapid blood culture identification technology and stewardship intervention on treatment of blood cultures contaminated with coagulase-negative staphylococci. The article reviewed in this episode can be found here: https://academic.oup.com/ofid/article/10/8/ofad416/7233915

For more information about DASON, please visit: https://dason.medicine.duke.edu/

Ep.86 – PEN-FAST and Furious: The efficacy of the PEN-FAST tool in de-labeling previously reported penicillin allergies

Episode Notes

In this episode, University of Kentucky PGY2 Infectious Diseases Pharmacy Residents, Will Harris and Tyler Pitcock, discuss the recently published article evaluating the efficacy of the clinical decision tool, PEN-FAST, in de-labeling patients with reported penicillin allergies with one of the authors and Duke University Hospital Infectious Diseases Physicians, Dr. Nick Turner. The article reviewed in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/37459086/

For more information about DASON, please visit: https://dason.medicine.duke.edu/